A carregar...
Romosozumab: A Novel Agent in the Treatment for Postmenopausal Osteoporosis
Objective: To review the safety and efficacy of romosozumab (Evenity) in the treatment of osteoporosis in women. Data Sources: An English-language search of PubMed and Medline (1966 to August 2020) was conducted using the keywords romosozumab, sclerostin inhibitor, AMG785, and osteoporosis. Manufact...
Na minha lista:
| Publicado no: | J Pharm Technol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7809324/ https://ncbi.nlm.nih.gov/pubmed/34752536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122520967632 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|